Brief: Anteris Technologies Global Corp Says FDA Approves Duravr THV Global Pivotal Trial
02/11/2025 22:11
Nov 3 (Reuters) - Anteris Technologies Global Corp AVR.O: FDA APPROVES DURAVR THV GLOBAL PIVOTAL TRIAL Further company coverage: AVR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anteris Technologies Global
See all newsBrief: Anteris Announces Strategic Investment From Medtronic To Continue Advancing Tavr In $320 Million Aggregate Capital Raises
U.S. STOCKS ON THE MOVE-Oklo, AMD, Lam Research
U.S. STOCKS ON THE MOVE-Aligos, Intel, Travelers Companies
U.S. STOCKS ON THE MOVE-Teledyne, Arm Holdings, Nathan’s Famous
U.S. STOCKS ON THE MOVE-United Airlines, TE Connectivity, Halliburton